Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Historical Retrospective Study on Fluvoxamine Therapy in Mild to Moderate COVID-19 via Telehealth
TCTR20230401001Completed
- Sponsor
- Chulabhorn Royal Academy
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of fluvoxamine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Chulabhorn Royal Academy. Primary endpoint: Prevention of clinical deterioration. Started Apr 2021; status: completed.
02
Drugs
fluvoxamine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20230401001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230401001.